Lv523
906 积分 2022-11-14 加入
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
21天前
已完结
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
1个月前
已完结
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity
1个月前
已完结
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas
1个月前
已完结
Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets
1个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
1个月前
已完结
Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
1个月前
已完结
A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease
2个月前
已完结
Anti-tumor activity of camptothecin analog conjugate of a RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
2个月前
已完结
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
2个月前
已完结